Your browser doesn't support javascript.
loading
Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes.
Mather, Kieren J; Coskun, Tamer; Pratt, Edward J; Milicevic, Zvonko; Weerakkody, Govinda; Thomas, Melissa K; Haupt, Axel; Ruotolo, Giacomo.
Affiliation
  • Mather KJ; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Coskun T; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Pratt EJ; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Milicevic Z; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Weerakkody G; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Thomas MK; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Haupt A; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Ruotolo G; Eli Lilly and Company, Indianapolis, Indiana, USA.
Diabetes Obes Metab ; 26(2): 785-789, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37989596
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: United States